Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
PSA Quote, Financials, Valuation and Earnings
Last price:
$283.64
Seasonality move
:
2%
Day range:
$282.62 - $287.00
52-week range:
$256.60 - $369.99
Dividend yield:
4.2%
P/E ratio:
28.36x
P/S ratio:
10.64x
P/B ratio:
9.60x
Volume:
982.8K
Avg. volume:
880.5K
1-year change:
-6.58%
Market cap:
$50.1B
Revenue:
$4.7B
EPS (TTM):
$10.07
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.4B | $4.2B | $4.5B | $4.7B | |
| Revenue Growth (YoY) | 2.1% | 17.18% | 22.44% | 8.02% | 3.94% | |
| Cost of Revenues | $867.5M | $920.6M | $1.1B | $1.1B | $1.3B | |
| Gross Profit | $2B | $2.5B | $3.1B | $3.4B | $3.4B | |
| Gross Profit Margin | 70.24% | 73.05% | 74.82% | 74.59% | 73.21% | |
| R&D Expenses | $10.8M | -- | -- | -- | -- | |
| Selling, General & Admin | $64M | $76M | $71.7M | $80.6M | $106.7M | |
| Other Inc / (Exp) | -$16M | $344.6M | $2.3B | -$11.8M | $130.6M | |
| Operating Expenses | $636.5M | $789.4M | $959.8M | $1.1B | $1.2B | |
| Operating Income | $1.4B | $1.7B | $2.2B | $2.3B | $2.2B | |
| Net Interest Expenses | $34M | $78.5M | $95.8M | $136.3M | $242.7M | |
| EBT. Incl. Unusual Items | $1.4B | $2B | $4.4B | $2.2B | $2.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $12.4M | $14.3M | $10.8M | $4.7M | |
| Net Income to Company | $1.4B | $2B | $4.4B | $2.2B | $2.1B | |
| Minority Interest in Earnings | -$4M | -$6.4M | -$17.1M | -$11.8M | -$12.4M | |
| Net Income to Common Excl Extra Items | $1.4B | $2B | $4.3B | $2.1B | $2.1B | |
| Basic EPS (Cont. Ops) | $6.29 | $9.91 | $23.64 | $11.11 | $10.68 | |
| Diluted EPS (Cont. Ops) | $6.29 | $9.87 | $23.50 | $11.06 | $10.64 | |
| Weighted Average Basic Share | $174.5M | $174.9M | $175.3M | $175.5M | $175.4M | |
| Weighted Average Diluted Share | $174.6M | $175.6M | $176.3M | $176.1M | $176M | |
| EBITDA | $2B | $2.8B | $5.4B | $3.3B | $3.5B | |
| EBIT | $1.4B | $2.1B | $4.5B | $2.4B | $2.4B | |
| Revenue (Reported) | $2.9B | $3.4B | $4.2B | $4.5B | $4.7B | |
| Operating Income (Reported) | $1.4B | $1.7B | $2.2B | $2.3B | $2.2B | |
| Operating Income (Adjusted) | $1.4B | $2.1B | $4.5B | $2.4B | $2.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $767.3M | $973.4M | $1.1B | $1.2B | $1.2B | |
| Revenue Growth (YoY) | 6.71% | 26.87% | 12.41% | 5.76% | 2.24% | |
| Cost of Revenues | $228.4M | $261M | $288.3M | $324.5M | $331.8M | |
| Gross Profit | $538.8M | $712.4M | $805.9M | $832.7M | $851.3M | |
| Gross Profit Margin | 70.23% | 73.19% | 73.65% | 71.96% | 71.95% | |
| R&D Expenses | $1.8M | $2.8M | -- | -- | -- | |
| Selling, General & Admin | $16.2M | $17.5M | $17M | $21.3M | $25.2M | |
| Other Inc / (Exp) | $74.3M | $82M | -$19.6M | $46.1M | -$67.1M | |
| Operating Expenses | $166.4M | $245.2M | $238.6M | $306.5M | $307.9M | |
| Operating Income | $372.4M | $467.2M | $567.3M | $526.2M | $543.4M | |
| Net Interest Expenses | $12.4M | $33M | $24.2M | $59.1M | $64.1M | |
| EBT. Incl. Unusual Items | $434.3M | $516.3M | $523.5M | $513.2M | $412.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $3.1M | $1.5M | $1.4M | |
| Net Income to Company | $434.3M | $516.3M | $520.4M | $511.7M | $410.8M | |
| Minority Interest in Earnings | -$1.2M | -$2.4M | -$2.7M | -$2.7M | -$3M | |
| Net Income to Common Excl Extra Items | $433M | $513.9M | $517.7M | $508.9M | $407.8M | |
| Basic EPS (Cont. Ops) | $2.21 | $2.65 | $2.67 | $2.61 | $2.04 | |
| Diluted EPS (Cont. Ops) | $2.21 | $2.63 | $2.65 | $2.60 | $2.04 | |
| Weighted Average Basic Share | $174.6M | $175.2M | $175.5M | $175.7M | $175.4M | |
| Weighted Average Diluted Share | $174.8M | $176.3M | $176.2M | $176.4M | $175.9M | |
| EBITDA | $596.4M | $771.5M | $781.3M | $866.2M | $766.9M | |
| EBIT | $449.5M | $549.4M | $559.6M | $581M | $484.2M | |
| Revenue (Reported) | $767.3M | $973.4M | $1.1B | $1.2B | $1.2B | |
| Operating Income (Reported) | $372.4M | $467.2M | $567.3M | $526.2M | $543.4M | |
| Operating Income (Adjusted) | $449.5M | $549.4M | $559.6M | $581M | $484.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $3.6B | $4.3B | $4.6B | $4.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $871.2M | $953.2M | $1.1B | $1.2B | $1.3B | |
| Gross Profit | $2.1B | $2.7B | $3.2B | $3.4B | $3.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10.2M | -- | -- | -- | -- | |
| Selling, General & Admin | $66.5M | $77.3M | $71.1M | $85M | $110.5M | |
| Other Inc / (Exp) | $24.3M | $346.5M | $2.2B | $53.9M | $17.4M | |
| Operating Expenses | $649.1M | $868.2M | $953.2M | $1.1B | $1.2B | |
| Operating Income | $1.4B | $1.8B | $2.3B | $2.3B | $2.2B | |
| Net Interest Expenses | $38.9M | $93.1M | $87M | $171.2M | $247.7M | |
| EBT. Incl. Unusual Items | $1.4B | $2.1B | $4.4B | $2.2B | $2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $9.2M | $4.6M | |
| Net Income to Company | $1.4B | $2B | $4.4B | $2.2B | $2B | |
| Minority Interest in Earnings | -$4.3M | -$7.5M | -$17.5M | -$11.8M | -$12.7M | |
| Net Income to Common Excl Extra Items | $1.4B | $2B | $4.4B | $2.1B | $2B | |
| Basic EPS (Cont. Ops) | $6.70 | $10.35 | $23.65 | $11.05 | $10.10 | |
| Diluted EPS (Cont. Ops) | $6.70 | $10.29 | $23.51 | $11.01 | $10.07 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.1B | $3B | $5.4B | $3.4B | $3.4B | |
| EBIT | $1.5B | $2.2B | $4.5B | $2.4B | $2.3B | |
| Revenue (Reported) | $3B | $3.6B | $4.3B | $4.6B | $4.7B | |
| Operating Income (Reported) | $1.4B | $1.8B | $2.3B | $2.3B | $2.2B | |
| Operating Income (Adjusted) | $1.5B | $2.2B | $4.5B | $2.4B | $2.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $767.3M | $973.4M | $1.1B | $1.2B | $1.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $228.4M | $261M | $288.3M | $324.5M | $331.8M | |
| Gross Profit | $538.8M | $712.4M | $805.9M | $832.7M | $851.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.8M | $2.8M | -- | -- | -- | |
| Selling, General & Admin | $16.2M | $17.5M | $17M | $21.3M | $25.2M | |
| Other Inc / (Exp) | $74.3M | $82M | -$19.6M | $46.1M | -$67.1M | |
| Operating Expenses | $166.4M | $245.2M | $238.6M | $306.5M | $307.9M | |
| Operating Income | $372.4M | $467.2M | $567.3M | $526.2M | $543.4M | |
| Net Interest Expenses | $12.4M | $33M | $24.2M | $59.1M | $64.1M | |
| EBT. Incl. Unusual Items | $434.3M | $516.3M | $523.5M | $513.2M | $412.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $3.1M | $1.5M | $1.4M | |
| Net Income to Company | $434.3M | $516.3M | $520.4M | $511.7M | $410.8M | |
| Minority Interest in Earnings | -$1.2M | -$2.4M | -$2.7M | -$2.7M | -$3M | |
| Net Income to Common Excl Extra Items | $433M | $513.9M | $517.7M | $508.9M | $407.8M | |
| Basic EPS (Cont. Ops) | $2.21 | $2.65 | $2.67 | $2.61 | $2.04 | |
| Diluted EPS (Cont. Ops) | $2.21 | $2.63 | $2.65 | $2.60 | $2.04 | |
| Weighted Average Basic Share | $174.6M | $175.2M | $175.5M | $175.7M | $175.4M | |
| Weighted Average Diluted Share | $174.8M | $176.3M | $176.2M | $176.4M | $175.9M | |
| EBITDA | $596.4M | $771.5M | $781.3M | $866.2M | $766.9M | |
| EBIT | $449.5M | $549.4M | $559.6M | $581M | $484.2M | |
| Revenue (Reported) | $767.3M | $973.4M | $1.1B | $1.2B | $1.2B | |
| Operating Income (Reported) | $372.4M | $467.2M | $567.3M | $526.2M | $543.4M | |
| Operating Income (Adjusted) | $449.5M | $549.4M | $559.6M | $581M | $484.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $257.6M | $734.6M | $775.3M | $370M | $447.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $257.6M | $734.6M | $775.3M | $370M | $447.4M | |
| Property Plant And Equipment | $188.1M | $272.5M | $373M | $345.5M | $308.1M | |
| Long-Term Investments | $773M | $828.8M | $275.8M | $390.2M | $382.5M | |
| Goodwill | $165.8M | $165.8M | $165.8M | $165.8M | $165.8M | |
| Other Intangibles | $38.8M | $137.1M | $66.7M | $221.4M | $116.3M | |
| Other Long-Term Assets | $172.7M | $207.7M | $230.8M | $275.1M | $282.2M | |
| Total Assets | $11.8B | $17.4B | $17.6B | $19.8B | $19.8B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $394.7M | $482.1M | $514.7M | $599M | $588.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $394.7M | $482.1M | $514.7M | $599M | $588.2M | |
| Long-Term Debt | $2.5B | $7.5B | $6.9B | $9.1B | $9.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $8B | $7.4B | $9.7B | $9.9B | |
| Common Stock | $3.8B | $4.1B | $4.4B | $4.4B | $4.4B | |
| Other Common Equity Adj | -$43.4M | -$53.6M | -$80.3M | -$67.2M | -$72M | |
| Common Equity | $4.8B | $5.2B | $5.7B | $5.7B | $5.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $18M | $88.4M | $93.4M | $93.8M | $101M | |
| Total Equity | $8.6B | $9.4B | $10.2B | $10.1B | $9.8B | |
| Total Liabilities and Equity | $11.8B | $17.4B | $17.6B | $19.8B | $19.8B | |
| Cash and Short Terms | $257.6M | $734.6M | $775.3M | $370M | $447.4M | |
| Total Debt | $2.5B | $7.5B | $6.9B | $9.1B | $9.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $159.6M | $940.5M | $695.4M | $271.6M | $287.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $159.6M | $940.5M | $695.4M | $271.6M | $287.2M | |
| Property Plant And Equipment | $201.3M | $337.6M | $377.3M | $389.3M | $240.7M | |
| Long-Term Investments | $771.1M | $850.6M | $285.7M | $389M | $374.1M | |
| Goodwill | -- | $165.8M | $165.8M | $165.8M | $165.8M | |
| Other Intangibles | -- | $105.3M | $53.9M | $185.6M | $97.4M | |
| Other Long-Term Assets | $286.3M | $213.8M | $265.8M | $289.3M | $291.7M | |
| Total Assets | $12B | $17.7B | $17.5B | $19.6B | $19.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $368.3M | $454M | $470.4M | $504.2M | $520.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $368.3M | $454M | $470.4M | $504.2M | $520.5M | |
| Long-Term Debt | $3B | $7.4B | $6.9B | $9.1B | $9.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.4B | $7.9B | $7.4B | $9.6B | $9.9B | |
| Common Stock | $3.8B | $4.4B | $4.4B | $4.4B | $4.4B | |
| Other Common Equity Adj | -$49.3M | -$60.4M | -$76.4M | -$74.5M | -$58.2M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -$300M | $242.8M | -- | -- | -- | |
| Minority Interest, Total | $19.4M | $104.4M | $92.3M | $96.6M | $104.1M | |
| Total Equity | $8.6B | $9.8B | $10.1B | $10B | $9.7B | |
| Total Liabilities and Equity | $12B | $17.7B | $17.5B | $19.6B | $19.6B | |
| Cash and Short Terms | $159.6M | $940.5M | $695.4M | $271.6M | $287.2M | |
| Total Debt | $3B | $7.4B | $6.9B | $9.1B | $9.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.4B | $2B | $4.4B | $2.2B | $2.1B | |
| Depreciation & Amoritzation | $553.3M | $713.4M | $888.1M | $970.1M | $1.1B | |
| Stock-Based Compensation | $33.4M | $59.8M | $56.7M | $41.6M | $44.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2B | $2.5B | $3.1B | $3.2B | $3.1B | |
| Capital Expenditures | $170M | $270.2M | $459.8M | $461.1M | $420M | |
| Cash Acquisitions | -- | -- | $2.6B | -$2.2B | -- | |
| Cash From Investing | -$1.1B | -$5.6B | $1.1B | -$3.5B | -$1B | |
| Dividends Paid (Ex Special Dividend) | -$1.6B | -$1.6B | -$3.9B | -$2.3B | -$2.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $545.2M | $5B | -- | $2.2B | $1.2B | |
| Long-Term Debt Repaid | -$2M | -$2.2M | -$513.5M | -$8.3M | -$808.5M | |
| Repurchase of Common Stock | -$1.2B | -$1.2B | -- | -- | -$200M | |
| Other Financing Activities | -$2.8M | -$18M | -$49.4M | -$33.8M | -$26.8M | |
| Cash From Financing | -$1.1B | $3.5B | -$4.2B | -$112.9M | -$2.1B | |
| Beginning Cash (CF) | $433.6M | $282.6M | $761.3M | $805.2M | $400.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$150.5M | $478.2M | $43.9M | -$404.8M | $47M | |
| Ending Cash (CF) | $282.6M | $761.3M | $805.2M | $400.4M | $447.4M | |
| Levered Free Cash Flow | $1.9B | $2.3B | $2.7B | $2.8B | $2.7B | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $411.7M | $656.9M | $581.2M | $521.2M | -- | |
| Depreciation & Amoritzation | $172.7M | $218.7M | $222.1M | $283.3M | -- | |
| Stock-Based Compensation | $18.3M | $16.9M | $11.9M | $10.8M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $621.3M | $797.5M | $882.4M | $895.3M | -- | |
| Capital Expenditures | $54.1M | $112.9M | $101.6M | $102M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.3B | -$307.3M | -$335M | -$191.1M | -- | |
| Dividends Paid (Ex Special Dividend) | -$396.2M | -$399.9M | -$576.3M | -$574.6M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2B | -- | -- | $1.2B | -- | |
| Long-Term Debt Repaid | -$526K | -$236K | -$8.1M | -$808.4M | -- | |
| Repurchase of Common Stock | -$200M | -- | -- | -$200M | -- | |
| Other Financing Activities | -$2.9M | -$19.9M | -$11.7M | -$3.5M | -- | |
| Cash From Financing | $2B | -$416.6M | -$591.1M | -$432.9M | -- | |
| Beginning Cash (CF) | $185.2M | $967.9M | $725.8M | $302.2M | -- | |
| Foreign Exchange Rate Adjustment | -$5K | -$173K | -- | -- | -- | |
| Additions / Reductions | $321.2M | $73.6M | -$43.7M | $271.3M | -- | |
| Ending Cash (CF) | $506.4M | $1B | $682.1M | $573.5M | -- | |
| Levered Free Cash Flow | $567.2M | $684.6M | $780.8M | $793.3M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.4B | $2B | $4.4B | $2.2B | $2B | |
| Depreciation & Amoritzation | $564.2M | $788.7M | $887.7M | $1B | $1.1B | |
| Stock-Based Compensation | $42.1M | $59.3M | $52.6M | $42.1M | $44.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.1B | $2.7B | $3.2B | $3.2B | $3.2B | |
| Capital Expenditures | $149M | $333.2M | $456.9M | $469M | $373.6M | |
| Cash Acquisitions | -- | -- | $2.6B | -$2.2B | -- | |
| Cash From Investing | -$1.2B | -$5.4B | $1.2B | -$3.5B | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -$1.6B | -$1.6B | -$4.1B | -$2.3B | -$2.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $496.2M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2.1M | -$1.9M | -$513.4M | -$8.2M | -$808.5M | |
| Repurchase of Common Stock | -$1.5B | -- | -- | -- | -- | |
| Other Financing Activities | -$9.4M | -$23.1M | -$49.7M | -$29.2M | -$24.7M | |
| Cash From Financing | -$1.4B | $3.5B | -$4.6B | -$126.2M | -$2.1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$556.6M | $782.2M | -$242M | -$423.6M | -$15M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.9B | $2.4B | $2.7B | $2.7B | $2.8B | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $846M | $1.2B | $1.1B | $1B | $410.8M | |
| Depreciation & Amoritzation | $319.6M | $440.8M | $443.8M | $568.5M | $282.7M | |
| Stock-Based Compensation | $32.7M | $30.9M | $21.8M | $21.2M | $10.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.1B | $1.5B | $1.6B | $1.6B | $705.1M | |
| Capital Expenditures | $90.6M | $212.5M | $198.2M | $206.5M | $58M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.7B | -$595.8M | -$547.3M | -$377.7M | -$286.5M | |
| Dividends Paid (Ex Special Dividend) | -$792.4M | -$799.5M | -$1.2B | -$1.2B | -$575.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.5B | -- | -- | $1.2B | -- | |
| Long-Term Debt Repaid | -$1.1M | -$472K | -$8.2M | -$808.4M | -$33K | |
| Repurchase of Common Stock | -$500M | -- | -- | -$200M | -- | |
| Other Financing Activities | -$10.1M | -$32.2M | -$24.4M | -$11.7M | -$6.1M | |
| Cash From Financing | $1.8B | -$577.9M | -$1.2B | -$1B | -$578.8M | |
| Beginning Cash (CF) | $467.8M | $1.7B | $1.5B | $702.6M | $447.4M | |
| Foreign Exchange Rate Adjustment | $173K | -- | -- | -- | -- | |
| Additions / Reductions | $223.7M | $280.1M | -$123.1M | $173.1M | -$160.2M | |
| Ending Cash (CF) | $691.7M | $2B | $1.4B | $875.6M | $287.2M | |
| Levered Free Cash Flow | $1B | $1.2B | $1.4B | $1.4B | $647.1M | |
Get PSA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PSA
Sector
P/E ratio
28.36x
19.72x
PEG ratio
--
0.10x
P/B ratio
9.60x
0.83x
Price / LTM sales
10.64x
3.52x
Growth Metrics
PSA
Sector
Revenue growth
2.24%
1.23%
Earnings growth
-21.54%
-1.15%
Revenue (5-year growth)
10.46%
2.95%
Earnings forecast
$2.55
$0.17
Profitability
PSA
Sector
Profitability FY 2024
$3.4B
$203.5M
Return on invested capital
10.29%
1.76%
Return on assets
10%
1.52%
Return on equity
20.09%
3.28%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
30
Estimated Next Earnings Date
Jul
30
Balance Sheet
PSA
Sector
Total cash
$287.2M
$68M
Short term investments
--
$13.6M
Total assets
$19.8B
$3.3B
Long term debt
$9.4B
$1.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
